Stock Rich List
Nasdaq: PRLD

Prelude Therapeutics insiders

The officers, directors and 10% owners of Prelude Therapeutics Incorporated who hold the most stock, valued at the live PRLD price.

$3.26
PRLD today −$45K (−1.36%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
1
Their PRLD stock
$9.7M
Market value
$261M
Held by ranked insiders
3.72%

Insiders by value of PRLD holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Krishna VaddiCEO2,974,725$9.7M3.72%8992nd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Prelude Therapeutics; see each profile for the filing.